Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clariane SECHIX:CLARIP 60 Equity-to-Asset is 0.25 as of Jun. 2026, which is at its 10-year median of 0.25. GuruFocus rates CHIX:CLARIP with a GF Score™ of 60/100 and a GF Value™ of €2.53 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Clariane SE ranks worse than 76.87% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Clariane SE's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €3,619 Mil. Clariane SE's Total Assets for the quarter that ended in Jun. 2026 was €14,360 Mil.
Therefore, Clariane SE's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.25.
The historical rank and industry rank for Clariane SE's Equity-to-Asset or its related term are showing as below:
CHIX:CLARIp'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22 Med: 0.25 Max: 0.35
Current: 0.25
During the past 13 years, the highest Equity to Asset Ratio of Clariane SE was 0.35. The lowest was 0.22. And the median was 0.25.
CHIX:CLARIp's Equity-to-Asset is ranked worse than 76.87% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs CHIX:CLARIp: 0.25
Clariane SE (CHIX:CLARIp) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Clariane SE Equity-to-Asset Related Terms
Clariane SE Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Clariane SE's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:CLARIP vs HCA, THC, DVA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Clariane SE's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Clariane SE's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Clariane SE's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (CHIX:CLARIP) has a Equity-to-Asset of 0.25 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Clariane SE and its competitors. This is near median its historical median of 0.25. Over the past decade, Clariane SE's Equity-to-Asset has ranged from 0.22 to 0.35. According to the industry distribution chart, Clariane SE ranks #525 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 76.9%.
Is Clariane SE's Equity-to-Asset too high?
Clariane SE's current Equity-to-Asset of 0.25 is near median its 10-year median of 0.25. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 0.35. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Clariane SE's value of 0.25 is 47.9% below this industry median. Based on the distribution chart, Clariane SE ranks #525 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Clariane SE has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #525 out of 683 companies for Equity-to-Asset. This places Clariane SE in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Clariane SE's value of 0.25 is 47.9% below this benchmark. Historically, Clariane SE's own Equity-to-Asset has ranged from 0.22 to 0.35 over the past decade. While the company's 10-year median is 0.25 vs. the industry median of 0.48, Clariane SE has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current Equity-to-Asset of 0.25 is 47.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current Equity-to-Asset is 0.25, which is near median its own 10-year median of 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.53, compared to a current price of €4.06 — trading 60.5% above its estimated fair value. The current Equity-to-Asset is 0.25, which is near median its 10-year median of 0.25 and 47.9% below the Healthcare Providers & Services industry median of 0.48. Clariane SE's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current Equity-to-Asset is 0.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.06 is trading 60.5% above its estimated GF Value™ of €2.53.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for CHIX:CLARIP:
Equity-to-Asset: 0.25 (near median its 10-year median of 0.25)
GF Value™: €2.53 vs. price of €4.06 (60.5% above fair value)
Industry Position: 47.9% below the Healthcare Providers & Services median (#525 of 683)
No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
60GF Score
Get the complete analysis for CHIX:CLARIP
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:CLARIP has been successfully added to your 
